OXYCODONE AND ACETAMINOPHEN tablet

国: アメリカ合衆国

言語: 英語

ソース: NLM (National Library of Medicine)

有効成分:

OXYCODONE (UNII: CD35PMG570) (OXYCODONE - UNII:CD35PMG570), ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D)

から入手可能:

Rebel Distributors Corp

INN（国際名）:

OXYCODONE

構図:

OXYCODONE 10 mg

投与経路:

ORAL

処方タイプ:

PRESCRIPTION DRUG

適応症:

Oxycodone and Acetaminophen Tablets, USP are indicated for the relief of moderate to moderately severe pain. Oxycodone and acetaminophen tablets should not be administered to patients with known hypersensitivity to oxycodone, acetaminophen, or any other component of this product. Oxycodone is contraindicated in any situation where opioids are contraindicated including patients with significant respiratory depression (in unmonitored settings or the absence of resuscitative equipment) and patients with acute or severe bronchial asthma or hypercarbia. Oxycodone is contraindicated in the setting of suspected or known paralytic ileus. Oxycodone and acetaminophen tablets are a Schedule II controlled substance. Oxycodone is a mu-agonist opioid with an abuse liability similar to morphine. Oxycodone, like morphine and other opioids used in analgesia, can be abused and is subject to criminal diversion. Drug addiction is defined as an abnormal, compulsive use, use for non-medical purposes of a substance despite physical

製品概要:

Oxycodone and Acetaminophen Tablets USP, 10 mg / 325 mg are supplied as white to off-white, capsule-shaped, biconvex tablets, debossed “IP204” on obverse and plain on reverse. They are available as follows: Bottles of 40: NDC 21695-619-40 Bottles of 60: NDC 21695-619-60 Store at 20° to 25°C (68° to 77°F). [see USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure. DEA Order Form Required

認証ステータス:

Abbreviated New Drug Application

製品の特徴

OXYCODONE AND ACETAMINOPHEN- OXYCODONE AND ACETAMINOPHEN TABLET
REBEL DISTRIBUTORS CORP
----------
OXYCODONE AND ACETAMINOPHEN TABLETS, USP 10 MG / 325 MG CII
RX ONLY
DESCRIPTION
Each tablet for oral administration contains:
Oxycodone Hydrochloride, USP……………. 10 mg*
Acetaminophen, USP………………………325 mg
*10 mg oxycodone HCl is equivalent to 8.9637 mg of oxycodone.
Oxycodone and Acetaminophen Tablets, USP also contain the following
inactive ingredients: colloidal
silicon dioxide, crospovidone, magnesium stearate, microcrystalline
cellulose, povidone,
pregelatinized starch and stearic acid.
Oxycodone, 14-hydroxydihydrocodeinone, is a semisynthetic opioid
analgesic which occurs as a
white, odorless, crystalline powder having a saline, bitter taste. The
molecular formula for oxycodone
hydrochloride is C
H NO •HCl and the molecular weight 351.82. It is derived from the
opium
alkaloid thebaine, and may be represented by the following structural
formula:
Acetaminophen, 4’-hydroxyacetanilide, is a non-opiate,
non-salicylate analgesic and antipyretic which
occurs as a white, odorless, crystalline powder, possessing a slightly
bitter taste. The molecular
formula for acetaminophen is C H NO and the molecular weight is
151.16. It may be represented by
the following structural formula:
CLINICAL PHARMACOLOGY
CENTRAL NERVOUS SYSTEM
Oxycodone is a semisynthetic pure opioid agonist whose principal
therapeutic action is analgesia.
Other pharmacological effects of oxycodone include anxiolysis,
euphoria and feelings of relaxation.
These effects are mediated by receptors (notably μ and k) in the
central nervous system for endogenous
opioid-like compounds such as endorphins and enkephalins. Oxycodone
produces respiratory
depression through direct activity at respiratory centers in the brain
stem and depresses the cough
reflex by direct effect on the center of the medulla.
Acetaminophen is a non-opiate, non-salicylate analgesic and
antipyretic. The site and mechanism for the
analgesic effect of acetaminophe